Search for: "International Materials, Inc." Results 4481 - 4500 of 7,042
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Mar 2019, 5:52 am
Securities and Exchange Commission, on Wednesday, March 6, 2019 Tags: Arbitration, Board composition, Boards of Directors, Class actions, Disclosure, Diversity, Dual-class stock, Engagement, ESG, Institutional Investors, SEC, Securities regulation, Shareholder proposals SEC Enforcement for Internal Control Failures Posted by Nicolas Grabar, Sandra Flow and Alexander Janghorbani, Cleary Gottlieb Steen & Hamilton… [read post]
24 Apr 2012, 8:00 am by Hedge Fund Lawyer
• Are the fund’s marketing materials clear and concise? [read post]
29 Dec 2020, 9:05 pm by Coral Beach
This traceback investigation identified Thomson International Inc. as the likely source. [read post]
27 Feb 2010, 4:59 pm
" Id. at 389-90 (citations and internal quotation marks omitted). [read post]
8 Feb 2024, 7:47 am by Cynthia Marcotte Stamer
  Solutions Law Press, Inc. invites you to receive future updates by registering on our Solutions Law Press, Inc. [read post]
19 Dec 2023, 4:48 pm by Cynthia Marcotte Stamer
 On November 22, 2023, the Departments used their statutory authority (Internal Revenue Code Section 9816(c)(9), ERISA Section 716(c)(9), and PHS Act Section 2799A-1(c)(9)) to grant extensions in the following circumstances: Disputing parties may request additional time, beyond the current business day deadline, to respond to the certified IDR entity’s requests for additional information. [read post]
15 Dec 2023, 8:55 am by Cynthia Marcotte Stamer
  Solutions Law Press, Inc. invites you to receive future updates by registering on our Solutions Law Press, Inc. [read post]
16 Jun 2013, 9:36 pm by Jason Rantanen
By Paul Cole[1]             How does the Supreme Court decision of 13 June 2013 match international opinion on the patentability of biological material? [read post]
11 Oct 2021, 11:10 am by Emily Dai
The event will feature Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria; and Julie Gerberding, executive vice president and chief patient officer at Merck & Co., Inc. [read post]
24 Jul 2008, 10:00 pm
Horton, 206 N.W.2d 100, 103 (Iowa 1973).Internal policies of private entities - Cavcon, Inc. v. [read post]